Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pembrolizumab in Lymphopenic Metastatic Breast Cancer Patients Treated with Metronomic Cyclophosphamide: A Clinical and Translational Prospective Study.
Breast Cancer (Dove Med Press). 2023 Apr 27;15:311-325. doi: 10.2147/BCTT.S400055. eCollection 2023.
Breast Cancer (Dove Med Press). 2023.
PMID: 37139242
Free PMC article.
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.
Trédan O, Ménétrier-Caux C, Ray-Coquard I, Garin G, Cropet C, Verronèse E, Bachelot T, Rebattu P, Heudel PE, Cassier P, Chabaud S, Croughs T, Dupont P, Cadore AC, Clapisson G, Delgado A, Bardin-dit-Courageot C, Rigal C, N'Kodia A, Gilles-Afchain L, Morre M, Pérol D, Blay JY, Caux C.
Trédan O, et al.
Ann Oncol. 2015 Jul;26(7):1353-62. doi: 10.1093/annonc/mdv173. Epub 2015 Apr 7.
Ann Oncol. 2015.
PMID: 25851629
Free article.
Clinical Trial.
Item in Clipboard
Immune cell dysfunctions in breast cancer patients detected through whole blood multi-parametric flow cytometry assay.
Verronèse E, Delgado A, Valladeau-Guilemond J, Garin G, Guillemaut S, Tredan O, Ray-Coquard I, Bachelot T, N'Kodia A, Bardin-Dit-Courageot C, Rigal C, Pérol D, Caux C, Ménétrier-Caux C.
Verronèse E, et al.
Oncoimmunology. 2015 Nov 10;5(3):e1100791. doi: 10.1080/2162402X.2015.1100791. eCollection 2016 Mar.
Oncoimmunology. 2015.
PMID: 27141361
Free PMC article.
Item in Clipboard
ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.
Trédan O, Ménétrier-Caux C, Ray-Coquard I, Garin G, Cropet C, Verronèse E, Bachelot T, Rebattu P, Heudel PE, Cassier P, Chabaud S, Croughs T, Dupont P, Cadore AC, Clapisson G, Delgado A, Bardin-Dit-Courageot C, Rigal C, N'Kodia A, Gilles-Afchain L, Morre M, Pérol D, Blay JY, Caux C.
Trédan O, et al.
Ann Oncol. 2018 Feb 1;29(2):523. doi: 10.1093/annonc/mdx058.
Ann Oncol. 2018.
PMID: 28368453
Free article.
No abstract available.
Item in Clipboard
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers.
Voissière A, Gomez-Roca C, Chabaud S, Rodriguez C, Nkodia A, Berthet J, Montane L, Bidaux AS, Treilleux I, Eberst L, Terret C, Korakis I, Garin G, Pérol D, Delord JP, Caux C, Dubois B, Ménétrier-Caux C, Bendriss-Vermare N, Cassier PA.
Voissière A, et al. Among authors: nkodia a.
Sci Transl Med. 2024 Jan 24;16(731):eadd1834. doi: 10.1126/scitranslmed.add1834. Epub 2024 Jan 24.
Sci Transl Med. 2024.
PMID: 38266104
Item in Clipboard
[Prevalence and factors associated with smoking among adults living in the Moungali district of Brazzaville in 2021].
Nkodia AJ, Tsiobinda BE, Antaon JSS, Missongo SR, Tienkeu PDN, Milandou CHD.
Nkodia AJ, et al.
Pan Afr Med J. 2022 Sep 5;43:6. doi: 10.11604/pamj.2022.43.6.34180. eCollection 2022.
Pan Afr Med J. 2022.
PMID: 36284884
Free PMC article.
French.
Item in Clipboard
Cite
Cite